Does OBINUTUZUMAB Cause Hypogammaglobulinaemia? 162 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 162 reports of Hypogammaglobulinaemia have been filed in association with OBINUTUZUMAB (Gazyva). This represents 1.1% of all adverse event reports for OBINUTUZUMAB.
162
Reports of Hypogammaglobulinaemia with OBINUTUZUMAB
1.1%
of all OBINUTUZUMAB reports
11
Deaths
47
Hospitalizations
How Dangerous Is Hypogammaglobulinaemia From OBINUTUZUMAB?
Of the 162 reports, 11 (6.8%) resulted in death, 47 (29.0%) required hospitalization, and 2 (1.2%) were considered life-threatening.
Is Hypogammaglobulinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 162 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Hypogammaglobulinaemia?
RITUXIMAB (1,762)
CYCLOPHOSPHAMIDE (780)
PREDNISONE (501)
MYCOPHENOLATE MOFETIL (416)
DEXAMETHASONE (400)
TISAGENLECLEUCEL (374)
PREDNISOLONE (367)
VINCRISTINE (355)
DOXORUBICIN (348)
METHOTREXATE (328)
Which OBINUTUZUMAB Alternatives Have Lower Hypogammaglobulinaemia Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE